Envisagenics Announces Research Collaboration with Bristol Myers Squibb

cafead

Administrator
Staff member
  • cafead   Nov 29, 2022 at 10:42: AM
via Envisagenics, an Artificial Intelligence ("AI")-driven biotechnology company that delivers therapies for RNA splicing diseases, today announced a research collaboration agreement with Bristol-Myers Squibb (NYSE: BMY).

article source